Sponsor of the Day:
Jerkmate
https://pubmed.ncbi.nlm.nih.gov/19920956/
Preference for and adherence to oral phosphodiesterase-5 inhibitors in the treatment of erectile...
Sildenafil was the first orally administered phosphodiesterase-5 inhibitor approved for the treatment of erectile dysfunction. Its successful introduction into...
preferenceadherenceoralphosphodiesterase5
https://www.droracle.ai/articles/640275/what-is-the-efficacy-of-udenafil-phosphodiesterase-type-5
What is the efficacy of udenafil (phosphodiesterase type 5 inhibitor) compared to sildenafil...
For patients prioritizing maximum efficacy, sildenafil 50 mg is the superior choice, demonstrating the highest global efficacy among all PDE5 inhibitors, tho...
type 5efficacyudenafilphosphodiesteraseinhibitor
https://www.ncbi.nlm.nih.gov/Structure/pdb/1TB7
1TB7: Catalytic Domain Of Human Phosphodiesterase 4D In Complex With AMP
cAMP-specific 3',5'-cyclic phosphodiesterase...
catalyticdomainhumanphosphodiesterase4d